Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 5/2007

01-06-2007 | Original Paper

Low level of quality of life in patients with mental and behavioral disorders wanting complementary and alternative (kampo) therapy

Auteur: Kazuo Yamada

Gepubliceerd in: Quality of Life Research | Uitgave 5/2007

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Objective

To compare the quality of life (QOL) in patients with and without mental and behavioral disorders wanting to receive kampo, a type of complementary and alternative medicine (CAM), we investigated the QOL of patients using the World Health Organization Quality of Life Brief Scale (WHOQOL-BREF).

Methods

Seven hundred and twenty-nine outpatients with various diseases or disorders wanting to receive kampo therapy were recruited in the study. Two hundred and ninety-four patients (F-group) had mental or behavioral disorders. For these 729 patients, QOL was rated on the WHOQOL-BREF Japanese version.

Results

The average WHOQOL-BREF score of F-group (2.93 ± .54) was significantly lower than that of controls (3.23 ± .53). Especially, the average WHOQOL-BREF score of the 135 patients who had already been treated with modern medicines and wanted to be treated with kampo formulas to augment modern medicines (2.77 ± .55) was significantly lower than that of other patients.

Conclusion

QOL in patients with mental and behavioral disorders wanting to be treated with kampo who had already been treated with modern medicines was lower than that in patients with general medical conditions or with mental or behavioral disorders not treated with modern medicine.
Literatuur
1.
go back to reference Astin, J. A. (1998). Why patients use alternative medicine: Results of a national study. Journal of American Medical Association, 279, 1548–1553. CrossRef Astin, J. A. (1998). Why patients use alternative medicine: Results of a national study. Journal of American Medical Association, 279, 1548–1553. CrossRef
2.
go back to reference Burstein, H. J., Gelber, S., & Guadagnoli, E. et al. (1999). Use of alternative medicine by women with early-stage breast cancer. New England Journal of Medicine, 340, 1733–1739. PubMedCrossRef Burstein, H. J., Gelber, S., & Guadagnoli, E. et al. (1999). Use of alternative medicine by women with early-stage breast cancer. New England Journal of Medicine, 340, 1733–1739. PubMedCrossRef
3.
go back to reference Eisenburg, D. M., Davis, R. B., & Ettner, S. L. et al. (1998). Trends in alternative medicine use in the United States, 1990–1997: Results of a follow-up national survey. Journal of American Medical Association, 280, 1569–1575. CrossRef Eisenburg, D. M., Davis, R. B., & Ettner, S. L. et al. (1998). Trends in alternative medicine use in the United States, 1990–1997: Results of a follow-up national survey. Journal of American Medical Association, 280, 1569–1575. CrossRef
4.
go back to reference Ernst, E. (2000). Prevalence of use of complementary/alternative medicine: A systematic review. Bulletin of the World Health Organization, 78, 252–257. PubMed Ernst, E. (2000). Prevalence of use of complementary/alternative medicine: A systematic review. Bulletin of the World Health Organization, 78, 252–257. PubMed
5.
go back to reference Kanba, S., Yamada, K., & Mizushima, H. et al. (1999). Use of herbal medicine for treating psychiatric disorders in Japan. In S. Kanba & E. Richelson (Eds.), Herbal medicine for neuropsychiatric diseases (pp. 3–13). New York: Seiwa Shoten/Brunner-Mazel. Kanba, S., Yamada, K., & Mizushima, H. et al. (1999). Use of herbal medicine for treating psychiatric disorders in Japan. In S. Kanba & E. Richelson (Eds.), Herbal medicine for neuropsychiatric diseases (pp. 3–13). New York: Seiwa Shoten/Brunner-Mazel.
6.
go back to reference Mizushima, H., & Kanba, S. (1999). The use of Japanese herbal medicine in the treatment of medically unexplained physical symptoms. Journal of Psychosomatic Research, 46, 531–535. PubMedCrossRef Mizushima, H., & Kanba, S. (1999). The use of Japanese herbal medicine in the treatment of medically unexplained physical symptoms. Journal of Psychosomatic Research, 46, 531–535. PubMedCrossRef
7.
go back to reference Nakane, Y., Tazaki, M., & Miyaoka, E. (1999). WHOQOL-BREF survey of general population. Iryo-to-Shakai, 9, 123–131 (in Japanese). Nakane, Y., Tazaki, M., & Miyaoka, E. (1999). WHOQOL-BREF survey of general population. Iryo-to-Shakai, 9, 123–131 (in Japanese).
8.
go back to reference Rickhi, B., Quan, H., & Moritz, S. et al. (2003). Mental disorders and reasons for using complementary therapy. Canadian Journal of Psychiatry, 48, 475–479. Rickhi, B., Quan, H., & Moritz, S. et al. (2003). Mental disorders and reasons for using complementary therapy. Canadian Journal of Psychiatry, 48, 475–479.
9.
go back to reference Saxena, S., Carlson, D., & Billington, R. et al. (2001). The WHO quality of life assessment instrument (WHOQOL-Bref): The importance of its items for cross-cultural research. Quality of Life Research, 10, 711–721. PubMedCrossRef Saxena, S., Carlson, D., & Billington, R. et al. (2001). The WHO quality of life assessment instrument (WHOQOL-Bref): The importance of its items for cross-cultural research. Quality of Life Research, 10, 711–721. PubMedCrossRef
10.
go back to reference Terasawa, K. (1993). Kampo, Japanese oriental medicine. Tokyo: KK Standard McIntyre. Terasawa, K. (1993). Kampo, Japanese oriental medicine. Tokyo: KK Standard McIntyre.
11.
go back to reference The WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28, 551–558. CrossRef The WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28, 551–558. CrossRef
12.
go back to reference The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHO-QOL). (1998). Development and general psychometric properties. WHO/MNH/PSF/97.4. Geneva: WHO. The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHO-QOL). (1998). Development and general psychometric properties. WHO/MNH/PSF/97.4. Geneva: WHO.
13.
go back to reference Wang, J. L., Patten, S. B., & Russell, M. L. (2001). Alternative medicine use by individuals with major depression. Canadian Journal of Psychiatry, 46, 528–533. Wang, J. L., Patten, S. B., & Russell, M. L. (2001). Alternative medicine use by individuals with major depression. Canadian Journal of Psychiatry, 46, 528–533.
14.
go back to reference Yamada, K., Den, R., & Ohnishi, K. et al. (2005). Effectiveness of herbal medicine (kampo) and changes of quality of life in patients with somatoform disorders. Journal of Clinical Psychopharmacology, 25, 199–201. PubMedCrossRef Yamada, K., Den, R., & Ohnishi, K. et al. (2005). Effectiveness of herbal medicine (kampo) and changes of quality of life in patients with somatoform disorders. Journal of Clinical Psychopharmacology, 25, 199–201. PubMedCrossRef
Metagegevens
Titel
Low level of quality of life in patients with mental and behavioral disorders wanting complementary and alternative (kampo) therapy
Auteur
Kazuo Yamada
Publicatiedatum
01-06-2007
Uitgeverij
Kluwer Academic Publishers
Gepubliceerd in
Quality of Life Research / Uitgave 5/2007
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-007-9179-3